Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by (Responsible Party):
David Thomas, Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01285050
First received: January 26, 2011
Last updated: February 22, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)